The covid-19 drug-associated APIs market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of 6%, as per The Business Research Company’s market report!

Read More On The COVID-19 Drug Associated APIs Market Report 2022 – https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

The COVID-19 Drug Associated APIs Market Size In 2022 And Forecast

The global covid-19 drug associated apis market is expected to grow from $5.55 billion in 2021 to $5.99 billion in 2022 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The COVID-19 drug-associated APIs market is expected to reach $7.55 billion in 2026 at a CAGR of 6%.

The COVID-19 drug-associated APIs market consists of sales of active pharmaceutical ingredients used in the manufacturing of COVID-19 drugs.

Request for A Sample Of The Global COVID-19 Drug Associated APIs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3248&type=smp

Increase In The Demand For Antivirals, Antimalarials, And Bronchodilators Is Driving The Growth Of The COVID-19 Drug Associated APIs Market

Remdesivir and Favipiravir are two common antiviral medications used currently for the treatment of COVID-19 patients. Remdesivir is a medication approved for emergency use in the USA and Japan for the treatment of COVID-19 patients. Remdesivir gained emergency use authorization (EUA) from the FDA on May 1, 2020, based on its preliminary data showing a faster time to recovery in hospitalized patients with several diseases. Favipiravir, which is used to treat influenza in Japan, has also shown a positive effect on COVID patients. As COVID-19 is a respiratory ailment, the demand for bronchodilators spiked significantly. Therefore, the increasing demand for antivirals, antimalarials, and bronchodilators is projected to boost the demand for the COVID-19-associated drug APIs market over the forecast period.

Competitive Landscape And The Regional Analysis Of The COVID-19 Drug Associated APIs Market

Major players in the covid-19 drug associated apis market are Dr. Reddy’s Laboratories, Lianyungang Guike Pharmaceutical, Alembic Pharmaceutical, Wockhardt Ltd, Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical (Haimen) Co Ltd, and Yatai Pharma.

Additionally, as per TBRC’s research – North America was the largest region in the covid-19 drug associated apis market in 2021 holding the largest market share and Middle East is expected to be the fastest-growing region in the forecast period.

The COVID-19 Drug Associated APIs Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the covid-19 drug associated apis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the covid-19 drug associated apis market.

Focusing On Strategies – A Key Trend In The COVID-19 Drug Associated APIs Market

Key players operating in the pharmaceutical industry that manufactures COVID-19 drug associated APIs are focusing on strategies such as plant capacity or production capacity expansion to meet the increasing demand due to the rising number of coronavirus cases across the globe.

COVID-19 Drug Associated APIs Market Segmentation By The Business Research Company

1) By Drug Class: Antimalarials, Bronchodilators, Antibiotics, Antivirals, Others

2) By Synthesis Type: Synthetic, Biotech

3) By Business Mode: Captive API, Merchant API

Here Are Some Reports Related To The COVID-19 Drug Associated APIs Market –

Coronavirus (COVID-19) Current Therapy Global Market Report 2022

Anti-Infective Drugs Global Market Report 2022

HP (High Potency) APIs Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: